of 1,200,000 ordinary shares at the ratio 20 percent of the current registered capital at the amount of THB 6,000,000 (Six million baht). As the above transaction, the Company
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on operating results and the financial position had varied over 20 percent for Q3/2018 ending on September 30
in 2019 showed a net loss of 16.4 million baht, which was lower than the third quarter in 2018 at 29.3 percent. The Company’s performance for the nine-month period for 2019 showed a net loss of 33.9
service income of 1,506.94 million baht, an increase from the year 2018 by 216.83 THB mn or representing an increase of 16.81 percent from the previous year, mainly come from the expansion of Backlog that
Share Purchase Agreement (“SPA”) to sell 3,249,998 shares (40.51 percent of the total SBITO’s shares) was signed on July 31, 2017, in which 1,604,444 shares were sold in phase one at the price of 71.49
Ref. No. U.SET 023/2018 10 May 2018 Subject: Acquisition of 30 Percent of Ordinary Shares in Vienna House (Thailand) Company Limited To: The President The Stock Exchange of Thailand U City Public
Profit Margin 5.5% 6.7% 6.3% -0.9% - The total revenues from the Company and its subsidiary is Baht 1,626.5 million which decreased from the previous year Baht 18.0 million or decreased at 1.1 percent
decreased by 8.4 percent from the same period previous year. The significant other income is income from scrap sales which are the results from the processing of cold rolled stainless steel sheet and coil
fixed interest rate from 2.05 to 3.01 percent per annum to reduce financial cost and risk management from floating interest rate. As a result, the Company has saved interest expense approximately by Baht